Balchem Corporation

NasdaqGS:BCPC Stock Report

Market Cap: US$4.9b

Balchem Management

Management criteria checks 4/4

Balchem's CEO is Ted Harris, appointed in Apr 2015, has a tenure of 10.58 years. total yearly compensation is $6.87M, comprised of 16.8% salary and 83.2% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth $9.38M. The average tenure of the management team and the board of directors is 3.5 years and 7.8 years respectively.

Key information

Ted Harris

Chief executive officer

US$6.9m

Total compensation

CEO salary percentage16.81%
CEO tenure10.6yrs
CEO ownership0.2%
Management average tenure3.5yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)

Oct 23

Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Oct 10
Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 17
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Mar 21
We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing

Mar 07
Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Jan 30
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Dec 06
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors

Nov 22
Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Balchem: A Tale Of Two Businesses

May 10

Balchem: Potential Turnaround Is In The Price

Feb 21

CEO Compensation Analysis

How has Ted Harris's remuneration changed compared to Balchem's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

US$149m

Jun 30 2025n/an/a

US$143m

Mar 31 2025n/an/a

US$137m

Dec 31 2024US$7mUS$1m

US$128m

Sep 30 2024n/an/a

US$122m

Jun 30 2024n/an/a

US$117m

Mar 31 2024n/an/a

US$115m

Dec 31 2023US$6mUS$1m

US$109m

Sep 30 2023n/an/a

US$103m

Jun 30 2023n/an/a

US$99m

Mar 31 2023n/an/a

US$99m

Dec 31 2022US$12mUS$1m

US$105m

Sep 30 2022n/an/a

US$109m

Jun 30 2022n/an/a

US$109m

Mar 31 2022n/an/a

US$102m

Dec 31 2021US$6mUS$1m

US$96m

Sep 30 2021n/an/a

US$93m

Jun 30 2021n/an/a

US$90m

Mar 31 2021n/an/a

US$88m

Dec 31 2020US$5mUS$1m

US$85m

Sep 30 2020n/an/a

US$83m

Jun 30 2020n/an/a

US$82m

Mar 31 2020n/an/a

US$81m

Dec 31 2019US$4mUS$915k

US$80m

Sep 30 2019n/an/a

US$80m

Jun 30 2019n/an/a

US$78m

Mar 31 2019n/an/a

US$78m

Dec 31 2018US$3mUS$800k

US$79m

Compensation vs Market: Ted's total compensation ($USD6.87M) is about average for companies of similar size in the US market ($USD8.28M).

Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.

CEO

Ted Harris (60 yo)

10.6yrs
Tenure
US$6,872,769
Compensation

Mr. Theodore Lee Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 3...

Leadership Team

NamePositionTenureCompensationOwnership
Theodore Harris
CEO, President & Chairman10.6yrsUS$6.87m0.19%
$ 9.4m
Carl Bengtsson
Executive VP6.8yrsUS$2.41m0.056%
$ 2.8m
Hatsuki Miyata
Executive VP3.3yrsUS$1.56m0.0089%
$ 439.1k
Martin Reid
Senior VP & Chief Supply Chain Officer4.8yrsUS$1.49m0.016%
$ 773.6k
Frederic Boned
Senior VP and GM of Human Nutrition & Health3yrsUS$1.88m0.0072%
$ 354.7k
William Backus
VP & Chief Accounting Officer14.4yrsUS$960.42k0.020%
$ 973.9k
Jonathan Griffin
Senior Vice President of Corporate Development1.7yrsUS$1.01mno data
M. Tignor
Senior VP & Chief Human Resources Officer3.8yrsno data0.032%
$ 1.6m
Job L. Gunsteren
Senior VP & GM of Specialty Products3.2yrsno datano data
George Graham
Senior VP and Chief R&D Officerless than a yearno data0.0077%
$ 380.9k
3.5yrs
Average Tenure
49yo
Average Age

Experienced Management: BCPC's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Theodore Harris
CEO, President & Chairman10.6yrsUS$6.87m0.19%
$ 9.4m
Daniel Knutson
Independent Director7.8yrsUS$233.65k0.012%
$ 606.3k
David Fischer
Independent Director15.2yrsUS$220.65k0.025%
$ 1.2m
Matthew Wineinger
Lead Independent Director10.2yrsUS$248.65k0.016%
$ 775.5k
Olivier Rigaud
Independent Director2.2yrsUS$218.65k0%
$ 0
Kathleen Fish
Independent Director4.4yrsUS$228.65k0.0016%
$ 77.5k
Monica Vicente
Independent Director2.2yrsUS$218.65k0%
$ 0
7.8yrs
Average Tenure
61yo
Average Age

Experienced Board: BCPC's board of directors are considered experienced (7.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/20 22:24
End of Day Share Price 2025/11/20 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Balchem Corporation is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.